Granisetron is a serotonin 5-HT₃ receptor antagonist used as an [[antiemetic]] to treat nausea and vomiting following chemotherapy and radiotherapy. Its main effect is to reduce the activity of the [[vagus nerve]], which is a nerve that activates the vomiting center in the [[medulla oblongata]].